- Home
- RVPH vs AIRG Comparison
RVPH vs AIRG Comparison
Compare RVPH & AIRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- AIRG
- Stock Information
- Founded
- RVPH 2006
- AIRG 1995
- Country
- RVPH United States
- AIRG United States
- Employees
- RVPH N/A
- AIRG N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- AIRG Radio And Television Broadcasting And Communications Equipment
- Sector
- RVPH Health Care
- AIRG Technology
- Exchange
- RVPH Nasdaq
- AIRG Nasdaq
- Market Cap
- RVPH 87.6M
- AIRG 80.0M
- IPO Year
- RVPH N/A
- AIRG 2016
- Fundamental
- Price
- RVPH $1.90
- AIRG $8.03
- Analyst Decision
- RVPH Strong Buy
- AIRG Strong Buy
- Analyst Count
- RVPH 5
- AIRG 2
- Target Price
- RVPH $11.40
- AIRG $11.75
- AVG Volume (30 Days)
- RVPH 3.0M
- AIRG 31.4K
- Earning Date
- RVPH 11-14-2024
- AIRG 03-05-2025
- Dividend Yield
- RVPH N/A
- AIRG N/A
- EPS Growth
- RVPH N/A
- AIRG N/A
- EPS
- RVPH N/A
- AIRG N/A
- Revenue
- RVPH N/A
- AIRG $55,586,000.00
- Revenue This Year
- RVPH N/A
- AIRG $14.12
- Revenue Next Year
- RVPH N/A
- AIRG $15.47
- P/E Ratio
- RVPH N/A
- AIRG N/A
- Revenue Growth
- RVPH N/A
- AIRG N/A
- 52 Week Low
- RVPH $0.60
- AIRG $3.40
- 52 Week High
- RVPH $4.83
- AIRG $10.34
- Technical
- Relative Strength Index (RSI)
- RVPH 52.37
- AIRG 63.79
- Support Level
- RVPH $1.56
- AIRG $5.90
- Resistance Level
- RVPH $2.06
- AIRG $8.47
- Average True Range (ATR)
- RVPH 0.23
- AIRG 0.42
- MACD
- RVPH -0.01
- AIRG 0.29
- Stochastic Oscillator
- RVPH 52.46
- AIRG 99.61
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.
About AIRG Airgain Inc.
Airgain Inc is engaged in providing antenna technologies. These technologies can be used to enable performance wireless networking across devices and markets which include connected homes, enterprises, automotive, and the Internet of Things. It also provides solutions to complex radio frequency, engineering challenges, and improving wireless service that require higher throughput, broad coverage footprint, and carrier-grade quality. Geographically, it derives maximum revenue from North America and also has a presence in China and the Rest of the World. The company products include Antenna Plus: Fleet, M2M, IoT Antennas, Carrier-Class Antenna, Embedded Antennas, and External Dipole Antennas.